ClinicalTrials.Veeva

Menu

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status and phase

Completed
Early Phase 1

Conditions

Current or Past Cigarette Smoker
Lung Cancer Screening

Treatments

Behavioral: In-depth interviews
Behavioral: Navigation
Behavioral: Surveys
Behavioral: Focus groups

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.

Full description

The study first used qualitative methods to inform the adaptation of a CHW model to facilitate lung cancer screening completion in an extremely high-risk group, NYC Chinese livery drivers who smoke or who quit within the past 15 years. A series of focus groups with Chinese livery drivers who smoke, a series of in-depth interviews with livery base management and staff, primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community were conducted to explore barriers and factors related to cancer screening. Findings were used to develop adapted intervention materials, including a CHW Manual for Facilitating Shared Decision Making and Lung Cancer Screening. Once adaptation is complete, the researchers will conduct a pre-pilot to refine the adapted CHW intervention materials. The researchers will then conduct a pilot randomized controlled trial (RCT) to assess the feasibility of the refined CHW model (intervention) versus written materials (control) to facilitate SDM and LCS (when appropriate) in an extremely high-risk group, NYC Chinese livery drivers eligible (by USPTSF criteria) for LCS. Feasibility results will be used to inform the planning and design of large scale RCTs, targeting Chinese drivers, as well as other driver populations in NYC and throughout the U.S., and other high risk Chinese smoking populations in other occupations (e.g. restaurant work, construction). The study is currently in the pre-pilot phase and expects to launch the pilot phase by the summer of 2020. Due to the effects of the COVID-19 crisis, the researchers have extended the pre-pilot participation time frame to 12 months. The study population has also indicated concern to attend doctor's appointments for SDM/LCS during COVID-19. As such, MSK is extending the study time frame to an additional 6 months. . CHWs will also be hosting health education workshops at community organizations, family associations, and public libraries. These workshops will be conducted in English, Mandarin, and Cantonese and cover topics including smoking cessation and lung cancer screening.

Enrollment

99 patients

Sex

All

Ages

21 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Focus Group Participants:

  • Of Chinese descent
  • Non-U.S. born
  • Fluent in Mandarin
  • Livery driver
  • Age 45-80
  • Current or past (within 15 years) cigarette smoker (no specific pack year requirement)

In Depth Interview Participants Livery Staff

  • Of Chinese descent
  • Non-U.S. born
  • Fluent in Mandarin
  • Livery base owner or employee
  • Age ≥ 21

Health Care Providers and Administrators:

  • Primary care physician, clinic director, hospital administrator, or radiology facility or department administrator
  • Age ≥ 21
  • Fluent in English

CHW pre-pilot RCT participants:

  • Of Chinese descent
  • Fluent in Mandarin
  • Male
  • Livery driver
  • Age 55-80 years old
  • Driven for 3 months or longer
  • 30 pack year history
  • Current smoker or quit within 15 years
  • Will not be traveling out of New York Area for more than 1 month in the next 3 months

CHW pilot RCT participants

  • Of Chinese descent
  • Fluent in Mandarin or Cantonese
  • Male
  • Professional driver
  • Age 50-80 years old
  • Driven for 3 months or longer
  • Last drove professionally within the last 18 months with plans of returning
  • 20 pack year smoking history
  • Current smoker or quit within 15 years
  • Will not be traveling out of New York Area for more than 3 months in the next 12 months
  • Has not completed LDCT in the past year.

Exclusion criteria

  • Has a household member who has already participated (or agreed to participate).

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

99 participants in 5 patient groups

Pilot RCT Control Group
Active Comparator group
Description:
Eligible NYC Chinese livery drivers will receive written materials only
Treatment:
Behavioral: Surveys
Pilot RCT CHW Intervention Group
Experimental group
Description:
Eligible NYC Chinese livery drivers will receive written materials and navigation for shared decision making (SDM) and lung cancer screening (LCS).
Treatment:
Behavioral: Navigation
Behavioral: Surveys
Focus Group
Experimental group
Description:
The investigators conducted a series of 4-6 focus groups with Chinese livery drivers who (currently, or in the past) smoke.
Treatment:
Behavioral: Focus groups
In-Depth Interview Group
Experimental group
Description:
12-15 in-depth interviews with livery base management and staff, and with 12-15 primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community.
Treatment:
Behavioral: In-depth interviews
Pre-pilot Group
Experimental group
Description:
Approximately 10 Chinese livery drivers who smoke or who quit smoking with the past 15 years and have a 30 pack-year history of smoking
Treatment:
Behavioral: Navigation
Behavioral: Surveys

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems